Ping Zhu

This inventor holds 20 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in Antibody-Drug Conjugates. Top assignees: Eisai R&d Management Co., Ltd., Arrowhead Pharmaceuticals, Inc., Novartis Ag. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ping Zhu. Retrieved from https://idiyas.com/inventor/ping-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 7)

% Patents Active = 95.0

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 8.7

ph-index = 4

Forward Citations = 26(Granted Patents)

Location History:

Cambridge, MA (US) (2013 - 2021)
Boxboro, MA (US) (2022)
Boxborough, MA (US) (2012 - 2023)
Acton, MA (US) (2022 - 2024)

Company Filing History:

11 out of 530

Eisai R&d Management Co., Ltd.

patents

4 out of 102

Arrowhead Pharmaceuticals, Inc.

Arrowhead Research Corporation

patents

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Antibody-Drug Conjugates

Splicing Modulators

HSF1-related Diseases

Splice Variants

Combination Therapies

Tetrasubstituted Alkenes

BCL2 Inhibitors

Neomorphic Mutants

Organic Compositions

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12514926 - SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE (2026-01-06),

2. 12172986 - Splicing modulator antibody-drug conjugates and methods of use (2024-12-24),

3. 12091661 - Organic compositions to treat HSF1-related diseases (2024-09-17),

4. 12043670 - Anti-BCMA antibody-drug conjugates and methods of use (2024-07-23),

5. 11998544 - Methods of using splicing modulators (2024-06-04),

6. 11945807 - Splicing modulator antibody-drug conjugates and methods of use (2024-04-02),

7. 11761045 - Splice variants associated with neomorphic SF3B1 mutants (2023-09-19),

8. 11524009 - Combination comprising at least one spliceosome modulator and at least one inhibitor chosen from BCL2 inhibitors, BCL2/BCLxL inhibitors, and BCLxL inhibitors and methods of use (2022-12-13),

9. 11352348 - Splicing modulator antibody-drug conjugates and methods of use (2022-06-07),

10. 11091761 - Organic compositions to treat HSF1-related diseases (2021-08-17),

11. 10889866 - Splice variants associated with neomorphic SF3B1 mutants (2021-01-12),

12. 10851065 - Tetrasubstituted alkene compounds and their use (2020-12-01),

13. 10287582 - Organic compositions to treat HSF1-related diseases (2019-05-14),

14. 10011874 - Androgen receptor mutation (2018-07-03),

15. 9796683 - Tetrasubstituted alkene compounds and their use (2017-10-24),

Title: The Innovative Mind of Ping Zhu

Introduction: Ping Zhu, a talented inventor based in Cambridge, MA, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ping Zhu's recent patents include a revolutionary AI-powered healthcare device designed to improve patient monitoring and a cutting-edge renewable energy system that enhances sustainability in urban environments.

Career Highlights: With a background in engineering and a passion for problem-solving, Ping Zhu has successfully developed numerous inventions that have reshaped industries. His work has been recognized with prestigious awards for its impact on society.

Collaborations: Ping Zhu has collaborated with leading research institutions and tech companies to bring his ideas to life. His partnerships have led to the development of innovative solutions that address complex challenges in various sectors.

Conclusion: Ping Zhu's dedication to pushing the boundaries of innovation continues to inspire the next generation of inventors. His relentless pursuit of excellence and commitment to creating a positive change make him a true pioneer in the world of technology.

Profile summary based on public USPTO records.